Total Return chart Biogen Inc.

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-13 EDT			5-day change	1st Jan Change
209.03 ^USD	+4.96%		-3.28%	+18.77%

07-13	FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug	RE
07-13	Wedbush Raises Price Target on Biogen to $201 From $196, Keeps Neutral Rating	MT

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.